The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
The Federal Trade Commission found Pharmacy Benefit Managers profited billions by raising the prices of "specialty drugs." ...
FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...
CVS Caremark, OptumRx and St. Louis-based Express Scripts — are part of huge health conglomerates that also own insurers, ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
The markups helped the PBMs reap $7.3 billion from 2017 to 2022, the FTC found. The PBMs—owned by insurers Cigna, CVS Health and UnitedHealth Group—are supposed to help keep drug costs low for ...
Robert F. Kennedy Jr. has reportedly secured the votes needed for confirmation as Secretary of Health and Human Services (HHS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback